MiR-29c was down-regulated in tumor tissues and serum samples of ESCC patients and has also been found to reverse 5-FU resistance by silencing F-box only protein 31 (FBXO31) (Li et al., 2019). This evidence concerns the gene FBXO31 and neoplasm.